Amgen Inc (AMGN)
Financial leverage ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 91,839,000 | 97,154,000 | 65,121,000 | 61,165,000 | 62,948,000 |
| Total stockholders’ equity | US$ in thousands | 5,877,000 | 6,232,000 | 3,661,000 | 6,700,000 | 9,409,000 |
| Financial leverage ratio | 15.63 | 15.59 | 17.79 | 9.13 | 6.69 |
December 31, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $91,839,000K ÷ $5,877,000K
= 15.63
The financial leverage ratio of Amgen Inc has shown a significant increase over the years, indicating a higher level of financial leverage utilized by the company. As of December 31, 2020, the financial leverage ratio was 6.69, which rose to 9.13 by December 31, 2021. The ratio further increased to 17.79 by December 31, 2022, reflecting a substantial surge in leverage.
Although there was a slight decrease in the financial leverage ratio to 15.59 by December 31, 2023, the ratio remained relatively high. By December 31, 2024, the financial leverage ratio stood at 15.63, indicating that Amgen Inc continues to maintain a significant level of financial leverage in its capital structure. The trend suggests that the company may be relying more on debt financing to support its operations and growth initiatives.
Peer comparison
Dec 31, 2024